Seeking Alpha
View as an RSS Feed

Bret Jensen  

View Bret Jensen's Comments BY TICKER:
A, AA, AAPL, ABB, ABT, ABTL, ABX, ACLS, ACMP, ACTG, ACTV, ADBE, ADSK, AEP, AGCO, AGEN, AGU, AHH, AHT, AIG, AKS, ALJ, ALL, ALR, AMAT, AMGN, AMKR, AMTD, AMZG, AMZN, ANF, ANV, APA, APC, APL, ARCP, ARII, ARLP, ARO, ARP, ATRS, ATSG, ATVI, ATW, AU, AVGO, AVNR, AXAS, AXTI, AYR, AZN, BA, BAC, BAS, BAX, BBBY, BBEP, BBRY, BBT, BBW, BBY, BCEI, BGFV, BHI, BIDU, BIG, BIIB, BIOL, BK, BKCC, BKH, BKW, BLK, BMO, BMR, BNS, BP, BRCD, BRCM, BRKS, BTU, BWP, BX, BYI, C, CALL, CAT, CBI, CBOU, CDE, CELG, CEO, CERS, CGIX, CGR, CHK, CHL, CHMT, CJES, CLDT, CLF, CLMT, CLR, CMG, CMI, CMLP, CNAT, CNDO, CNP, CNQ, CNX, COF, COG, COH, COOL, COP, CORT, CPE, CPIX, CPSI, CRM, CROX, CRUS, CRZO, CSCO, CSX, CTCM, CVE, CVS, CVX, CXPO, CXS, CY, DAKT, DAN, DBC, DD, DDE, DECK, DENN, DG, DISH, DK, DNR, DO, DOW, DRH, DRIV, DSCO, DTLK, DTV, DUSA, DVAX, DVN, DVR, DWA, DXLG, E, EBAY, ECA, EDR, ELLI, ELY, EMC, END, ENDP, EOG, EOX, EPAM, EPAX, EPB, EPR, EQIX, EQM, EROC, ESIO, ESV, ETE, ETN, ETP, ETRM, EVEP, EWZ, EXK, EXLP, EXPE, EXXI, F, FANG, FB, FCH, FCX, FDX, FIG, FLL, FLY, FOLD, FOSL, FRD, FSC, FSII, FURX, FWLT, FXCM, GBX, GCOM, GE, GEF, GEOY, GERN, GES, GEVA, GFI, GILD, GLP, GLUU, GLW, GM, GNW, GOOG, GOOGL, GPOR, GPS, GS, GSK, GSM, GSS, GTATQ, GTE, HAL, HBM, HCBK, HCLP, HEP, HERO, HES, HFC, HIG, HL, HLF, HLX, HMA, HON, HOS, HP, HPQ, HPT, HRS, HRZN, HTA, HTGC, HURN, HZNP, IACI, IAG, IGTE, IMOS, INN, INT, INTC, INVN, IO, IPGP, IQNT, IRDM, IRET, IRT, ISRG, ITRI, ITT, IVAN, JAZZ, JDSU, JNJ, JNPR, JOY, JPM, KBH, KBR, KCG, KEG, KERX, KFY, KKR, KLAC, KLIC, KO, KOG, KONA, KR, KRG, KRO, LAD, LCI, LGCY, LIFE, LIME, LINE, LLL, LLNW, LLY, LMOS, LMT, LNCO, LNKD, LO, LOCO, LOW, LPRI, LSI, LUK, LULU, LVS, LXP, LYB, M, MANT, MCEP, MCHX, MCP, MDR, MDT, MELI, MEMP, MET, MHR, MITL, MMLP, MMP, MNK, MO, MOD, MOS, MPC, MPO, MPW, MRCY, MRGE, MRK, MRO, MRVL, MS, MSFT, MT, MTDR, MTOR, MTSN, MU, MUR, MXIM, MYL, MYRG, NAVB, NBL, NBR, NE, NEE, NEM, NEON, NFLX, NFX, NGLS, NGPC, NILE, NOG, NOK, NOV, NSC, NSPH, NTAP, NTSP, NUAN, NVAX, NVDA, NVS, NWY, NXPI, NYCB, NYX, OAS, OCN, OCZ, OHI, OIS, OKS, OPEN, OPLK, ORAN, ORCL, ORIG, ORLY, OUTR, OVTI, OXY, OZM, PAA, PAAS, PACD, PACR, PANW, PAYX, PBF, PBH, PBI, PBY, PCLN, PDH, PDLI, PDS, PEET, PEG, PES, PETM, PETS, PFE, PFMT, PGEM, PH, PM, PNG, PNK, PNRA, POM, POT, PRTA, PSX, PTEN, PULB, PVR, PWER, QCCO, QCOM, QLGC, QLTY, QRE, QUMU, R, RAIL, RAX, RCL, RDWR, REGN, RES, REXX, RF, RFMD, RIG, RIGL, RIO, RNN, ROC, ROSE, ROVI, RPRX, RRD, RSTI, RTEC, RTN, RUE, RUTH, RVBD, SAM, SARA, SBRA, SCLN, SCMR, SCO, SDRL, SEAC, SFY, SHOR, SIGA, SIMG, SIMO, SIRI, SKUL, SLB, SLCA, SM, SMCI, SN, SNH, SNY, SODA, SPLK, SPLS, SPN, SPPI, SPRT, SPY, SQNM, SSH, SSNLF, STI, STJ, STMP, STO, STT, STX, SUNE, SVU, SWFT, SWKS, SYNA, SYRG, T, TAL, TAP, TBT, TCAP, TDW, TEF, TER, TESO, TEVA, TEX, TGX, TICC, TIVO, TKR, TLLP, TOT, TPC, TPLM, TQNT, TRLG, TRN, TSLA, TSO, TST, TSYS, TTI, TWI, TWX, UA, UNH, UNIS, UPL, USB, V, VALE, VELTF, VICL, VLO, VMW, VNR, VOD, VRA, VXX, VZ, WAC, WAG, WDC, WEN, WFC, WFT, WHR, WIFI, WLL, WMT, WRES, XEC, XOM, XRX, YELP, YHOO, Z, ZAGG, ZEUS, ZIXI, ZLTQ, ZNGA
Latest comments  |  Highest rated
  • 3 'Safe' Biotech Picks [View article]
    LVS long term buy and hold here. Best positioned gaming play in Asia....comps should get better in second half and pays nearly 5% yield while you wait.
    Apr 27, 2015. 05:30 PM | Likes Like |Link to Comment
  • 2 Biotechs Under $5 That Could Light Up In 2015 [View article]
    Still speculative high risk/high reward bet. Thanks for the kind words.
    Apr 27, 2015. 04:21 PM | Likes Like |Link to Comment
  • 2 Small Biotech Stocks In Full Breakout Mode [View article]
    I recommended all the good ones....:-). Thanks for the kind words.
    Apr 27, 2015. 03:16 PM | Likes Like |Link to Comment
  • 3 'Safe' Biotech Picks [View article]
    Si, "Safe" is definitely relative in space. Would not be surprised if MRK knocked Viekera Pak out of #2 given its limitations.
    Apr 27, 2015. 10:54 AM | Likes Like |Link to Comment
  • 3 'Safe' Biotech Picks [View article]
    The CAR-T space has had a huge run, worried about a pull back. That being said, JUNO does have some interesting early stage candidates.
    Apr 27, 2015. 09:20 AM | Likes Like |Link to Comment
  • 3 'Safe' Biotech Picks [View article]
    Not if consensus RY2016 of ~$6 a share turns out to be correct.
    Apr 27, 2015. 04:41 AM | Likes Like |Link to Comment
  • 3 'Safe' Biotech Picks [View article]
    Own CELG as well. Only reason not on list is not paying dividend and 3 safe biotechs is a bit catchier than 4. Still great company.
    Apr 27, 2015. 04:40 AM | 3 Likes Like |Link to Comment
  • $5 Or Less: 3 Small, Speculative Biotechs On The Move [View article]
    $PGNX should get nice move Monday.

    The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopts a positive opinion recommending approval for Valeant Pharmaceuticals' (NYSE:VRX) Relistor (methylnaltrexone bromide) for the treatment of adult patients with opioid-induced constipation (OIC) when response to laxative therapy has not been sufficient. This is a larger population than the one allowed under the current label. The Committee also recommends a one-year extension of data/marketing protection for Relistor to 11 years from the date of approval, citing its benefits compared to existing therapies.Relistor is currently cleared for the treatment of OIC in adult patients with advanced illness who are receiving palliative care when response to laxative therapy has been insufficient.Relistor was developed by Progenics Pharmaceuticals (NASDAQ:PGNX) which licensed it to Salix Pharmaceuticals which was acquired by Valeant in February.
    Apr 24, 2015. 05:57 PM | Likes Like |Link to Comment
  • Agenus: A Speculative But Attractive $4 Small Cap Gem [View article]
    $AGEN in full breakout mode after its conference call with analysts yesterday.
    Apr 24, 2015. 04:01 PM | 3 Likes Like |Link to Comment
  • General Motors Shifts Into Third Gear [View article]
    Weird divergence, no? Can do worse than buying something growing at trading at 7 times forward earnings and yielding 4% imho
    Apr 24, 2015. 12:41 PM | Likes Like |Link to Comment
  • Eagle Pharmaceuticals: Even After 350% Rally, Shares Have Upside [View article]
    Glad you got a major winner.
    Apr 23, 2015. 07:24 PM | 2 Likes Like |Link to Comment
  • Gilead Sciences Reminds Me Of Apple Circa June 2013 [View article]
    Several Phase 2 studies evaluating investigational uses of Gilead Science's (GILD +0.3%) Harvoni (ledipasvir/sofosbuvir) and Sovaldi (sofosbuvir) show high cure rates in patients with advanced liver disease, including decompensated cirrhosis, fibrosing cholestatic hepatitis C (a rare and severe form of HCV infection following liver transplantation) and portal hypertension. Decompensated liver disease, characterized by jaundice (yellowing of eyes and skin), internal bleeding and/or fluid in the belly, is serious and life-threatening and requires a liver transplant.
    In the SOLAR-2 trial, HCV-1 or -4 patients with decompensated liver disease before liver transplantation were randomized to receive either 12 or 24 weeks of Harvoni plus ribavirin (RBV). The SVR12 rate was 86% (n=47/43) in the 12-week arm and 85% (n=35/41) in the 24-week arm. In the group of patients with recurrent HCV infection after receiving a new liver, those with non-cirrhotic and compensated cirrhosis showed SVR12 rates of 96% (n=72/75) and 98% (n=57/58), respectively, for the same two treatment cycles, while those with decompensated cirrhosis showed an SVR12 rate of 91% (n=20/22) and 95% (n=19/20).
    A subset of the SOLAR-1 and SOLAR-2 studies showed a cure (SVR12) rate of 100% in a group of 11 patients with fibrosing cholestatic hepatitis following 12 or 24 weeks of Harvoni plus RBV.
    The data will be presented at this week's 50th Annual Meeting of the European Association for the Study of the Liver in Vienna, Austria.
    Apr 23, 2015. 11:23 AM | 1 Like Like |Link to Comment
  • Endocyte: The Small Cap Gem Of The Week [View article]
    Sad fact that the U.S. graduates more lawyers annually than Japan has in entire country....they have to do something.
    Apr 23, 2015. 10:34 AM | 3 Likes Like |Link to Comment
  • Treasury: Frannie bailout was investment, not loan [View news story]
    Just another confiscation of private property by administration outside the code of law to fuel their spending. Long term consequences be damned, some other president will have to worry about those ramifications.
    Apr 23, 2015. 09:58 AM | 10 Likes Like |Link to Comment
  • Case Builds For Owning Amgen [View article]
    Like the call even better now.....

    Amgen (NASDAQ:AMGN): Q1 EPS of $2.48 beats by $0.38.
    Revenue of $5.03B (+11.3% Y/Y) beats by $120M.
    Apr 22, 2015. 08:56 AM | 1 Like Like |Link to Comment
COMMENTS STATS
11,107 Comments
12,033 Likes